Myricetin Inhibits SARS-CoV-2 Viral Replication by Targeting M(pro) and Ameliorates Pulmonary Inflammation

The coronavirus disease 2019 (COVID-19) has spread widely around the world and has seriously affected the human health of tens of millions of people. In view of lacking anti-virus drugs target to SARS-CoV-2, there is an urgent need to develop effective new drugs. In this study, we reported our disco...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiao, Ting, Cui, Mengqi, Zheng, Caijuan, Wang, Ming, Sun, Ronghao, Gao, Dandi, Bao, Jiali, Ren, Shanfa, Yang, Bo, Lin, Jianping, Li, Xiaoping, Li, Dongmei, Yang, Cheng, Zhou, Honggang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8248548/
https://www.ncbi.nlm.nih.gov/pubmed/34220507
http://dx.doi.org/10.3389/fphar.2021.669642

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8248548/
https://www.ncbi.nlm.nih.gov/pubmed/34220507
http://dx.doi.org/10.3389/fphar.2021.669642

Ejemplares similares